Company profile · Hamburg, Germany

Evotec

Drug Discovery and Platform Development · Global research platform

Evotec remains a verified German discovery-and-platform anchor with explicit cluster linkage to major therapeutic and industrial partners.

Lead
Dr. Christian Wojczewski (verified ↗)
Address
Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany (source ↗)
Compliance
GLP
Last reviewed
14 Mar 2026 (3mo ago)
Scale
Global research platform
Capabilities
Integrated Drug Discovery · Translational Biology · Biologics and Platform Partnerships
Founded
1993
Headcount
1001-5000
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Dr. Christian Wojczewski

Chief Executive Officer and Chair of the Management Board

Check official leadership source
Full addressManfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official Evotec worldwide locations page naming the Manfred Eigen Campus at Essener Bogen 7 in Hamburg.

Open source
Operating profile

Global research platform

Hamburg, Germany. Drug Discovery and Platform Development. Review completed on 14 Mar 2026.

2026 technical specializationDrug Discovery and Platform Development
Core capabilities
Integrated Drug DiscoveryTranslational BiologyBiologics and Platform Partnerships
Governance

German and EU biopharma research oversight

Integrated R&D Platform, Industrial Biotech Partnerships

Editorial note

Drug Discovery and Platform Development

Evotec remains a verified German discovery-and-platform anchor with explicit cluster linkage to major therapeutic and industrial partners.

Related companies
Editorial note

Evotec remains a verified German discovery-and-platform anchor with explicit cluster linkage to major therapeutic and industrial partners.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 14 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Integrated Drug Discovery
Translational Biology
Biologics and Platform Partnerships
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceEvotec management board page naming Dr. Christian Wojczewski as CEO.Source origin: evotec.comOpen source
Supporting evidenceEvotec 2024 fiscal year results release confirming Dr. Christian Wojczewski as CEO from July 1, 2024.Source origin: evotec.comOpen source
Physical-site evidenceOfficial Evotec worldwide locations page naming the Manfred Eigen Campus at Essener Bogen 7 in Hamburg.Source origin: evotec.comOpen source
Infrastructure

Declared infrastructure

High-throughput screening
Discovery biology labs
Biologics partnership infrastructure
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
VERIFIED ACTIVE 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Evotec located?
Evotec operates from Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany, Hamburg, Germany.
Who runs Evotec?
Evotec is led by Dr. Christian Wojczewski, Chief Executive Officer and Chair of the Management Board. Verified 14 Mar 2026.
What does Evotec do?
Evotec remains a verified German discovery-and-platform anchor with explicit cluster linkage to major therapeutic and industrial partners. Core capabilities: Integrated Drug Discovery, Translational Biology, Biologics and Platform Partnerships.
Editorial context

Related technical briefs

Briefs that name Hamburg as a covered market or city.